Interestingly, four genes (TIMP1, SERPINE1, PLAUR and PTX3) associated with poor overall survival of both LUAD and LUSC patients, are involved in the regulation of ECM remodelling [130–133], which plays a key role in the aggravation of tumour malignancy and metastasis [134]. The gene discussed is PLAUR; the disease is neoplasm.